Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells

Pharmacology and Toxicology

Volumn 91, Issue 3, 2002, Pages 116-122

  Mäenpää, Hanna ^a,c   Mannerström, Marika ^a   Toimela, Tarja ^a   Salminen, Lotta ^a,b   Saransaari, Pirjo ^a   Tähti, Hanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c Medical School   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOPHILE; ASPARTIC ACID; CHLOROQUINE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; NEUROTRANSMITTER; TAMOXIFEN; TOREMIFENE; TRACER; VISUAL PIGMENT;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG INHIBITION; DRUG SCREENING; EPITHELIUM CELL; HUMAN; HUMAN CELL; IC 50; LIQUID SCINTILLATION COUNTING; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RADIOACTIVITY; RETINA DISEASE; SODIUM TRANSPORT; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0036750999     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910305.x     Document Type: Article

References (60)

1. Anderson, C. M., R. J. Bridges, A. R. Chamberlin, K. shimamoto, Y. Yasuda-Kamatani & R. A. Swanson: Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal. J. Neurochem. 2001, 79, 1207-1216.
2. Anttila, M., R. Valavaara, S. Kivinen & J. Maenpaa: Pharmacokinetics of toremifene. J. Steroid Biochem. 1990, 36, 249-252.
3. Arriza, J. L., W. A. Fairman, J. I. Wadiche, G. H. Murdoch, M. P. Kavanaugh & S. G. Amara: Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 1994, 14, 5559-5569.
4. Barnett, N. L. & D. V. Pow: Antisense knockdown of GLAST, a glial glutamate transporter, compromises retinal function. Invest. Ophthalmol. Vis. Sci. 2000, 41, 585-591.
5. Besharse, J. C. & D. M. Defoe: Role of retinal pigment epithelium in photoreceptor membrane turnover. In: The retinal pigment epithelium. Vol. 1 Eds.: M. F. Marmor and T. J. Wolfensberger. Oxford University Press, New York, USA, 1998, pp. 152-172.
6. Bignon, E., M. Pons, J. C. Dore, J. Gilbert, T. Ojasoo, J. F. Miquel, J. P. Raynaud & D. P. Crastes: Influence of di- and tri-phenylethylene estrogen/antiestrogen structure on the mechanisms of protein kinase C inhibition and activation as revealed by a multivariate analysis. Biochem. Pharmacol. 1991, 42, 1373-1383.
7. Bruinink, A., G. Zimmermann & F. Riesen: Neurotoxic effects of chloroquine in vitro. Arch. Toxicol. 1991, 65, 480-484.
8. Burke, J. M. & C. M. Skumatz: Autofluorescent inclusions in long-term postconfluent cultures of retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1998, 39, 1478-1486.
9. Burke, J. M., C. M. Skumatz, P. E. Irving & B. S. McKay: Phenotypic heterogeneity of retinal pigment epithelial cells in vitro and in situ. Exp. Eye Res. 1996, 62, 63-73.
10. Buzdar, A. U. & G. N. Hortobagyi: Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy. J. Clin. Oncol. 1998, 16, 348-353.
11. Casado, M., A. Bendahan, F. Zafra, N. C. Danbolt, C. Aragon, C. Gimenez & B. I. Kanner: Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J. Biol. Chem. 1993, 268, 27313-27317.
12. Chern, S. & R. P. Danis: Retinopathy associated with low-dose tamoxifen. Amer. J. Ophthalmol. 1993, 116, 372-373.
13. Choi, D. W.: Excitotoxic cell death. J. Neurobiol. 1992, 23, 1261-1276.
14. Danbolt, N. C.: Glutamate uptake. Prog. Neurobiol. 2001, 65, 1-105.
15. Davis, A. A., P. S. Bernstein, D. Bok, J. Turner, M. Nachtigal & R. C. Hunt: A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest. Ophthalmol Vis. Sci. 1995, 36, 955-964.
16. Derouiche, A. & T. Rauen: Coincidence of L-glutamate/L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearance. J. Neurosci. Res. 1995, 42, 131-143.
17. Duan, S., C. M. Anderson, B. A. Stein & R. A. Swanson: Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J. Neurosci. 1999, 19, 10193-10200.
18. El-Sayed, N. K., L. R. Abdel-Khalek, K. M. Gaafar & L. K. Hanafy: Profiles of serum proteins and free amino acids associated with chloroquine retinopathy. Acta Ophthalmol. Scand. 1998, 76, 422-430.
19. Eliasof, S., J. L. Arriza, B. H. Leighton, M. P. Kavanaugh & S. G. Amara: Excitatory amino acid transporters of the salamander retina: identification, localization, and function. J. Neurosci. 1998, 18, 698-712.
20. Ganel, R. & C. E. Crosson: Modulation of human glutamate transporter activity by phorbol ester. J. Neurochem. 1998, 70, 993-1000.
21. Greenberger, L. M. & J. C. Besharse: Stimulation of photoreceptor disc shedding and pigment epithelial phagocytosis by glutamate, aspartate, and other amino acids. J. Comp. Neurol. 1985, 239, 361-372.
22. Grisanti, S. & C. Guidry: Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest. Ophthalmol. Vis. Sci. 1995, 36, 391-405.
23. Hard, G. C., M. J. Iatropoulos, K. Jordan, L. Radi, O. P. Kaltenberg, A. R. Imondi & G. M. Williams: Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res. 1993, 53, 4534-4541.
24. Hediger, M. A.: Glutamate transporters in kidney and brain. Amer. J. Physiol. 1999, 277, F487-F492.
25. Holli, K.: Adjuvant trials of toremifene vs tamoxifen: the European experience. Oncology (Huntingt). 1998, 12, 23-27.
26. Jarzyna, R., E. Lenarcik & J. Bryla: Chloroquine is a potent inhibitor of glutamate dehydrogenase in liver and kidney-cortex of rabbit. Pharmacol. Res. 1997, 35, 79-84.
27. Jordan, V. C.: Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat. 1994, 31, 41-52.
28. Kanai, Y., M. Stelzner, S. Nussberger, S. Khawaja, S. C. Hebert, C. P. Smith & M. A. Hediger: The neuronal and epithelial human high affinity glutamate transporter. Insights into structure and mechanism of transport. J. Biol. Chem. 1994, 269, 20599-20606.
29. Kanner, B. I. & I. Sharon: Active transport of L-glutamate by membrane vesicles isolated from rat brain. Biochemistry 1978, 17, 3949-3953.
30. Lehre, K. P., S. Davanger & N. C. Danbolt: Localization of the glutamate transporter protein GLAST in rat retina. Brain Res. 1997, 744, 129-137.
31. Lien, E. A., E. Solheim & P. M. Ueland: Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res. 1991, 51, 4837-4844.
32. López-Colomé, A. M., G. Fragoso, C. E. Wright & J. A. Sturman: Excitatory amino acid receptors in membranes from cultured human retinal pigment epithelium. Curr. Eye Res. 1994, 13, 553-560.
33. Mannerström, M., H. Mäenpää, T. Toimela, L. Salminen & H. Tähti: The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures. Pharmacology & Toxicology 2001, 88, 27-33.
34. Marc, R. E., R. F. Murry, S. K. Fisher, K. A. Linberg & G. P. Lewis: Amino acid signatures in the detached cat retina. Invest. Ophthalmol. Vis. Sci. 1998a, 39, 1694-1702.
35. Marc, R. E., R. F. Murry, S. K. Fisher, K. A. Linberg, G. P. Lewis & M. Kalloniatis: Amino acid signatures in the normal cat retina. Invest. Ophthalmol. Vis. Sci. 1998b, 39, 1685-1693.
36. Massey, S. C.: Cell types using glutamate as a neurotransmitter in the vertebrate retina. In: Progress in retinal research. Eds.: N. Osborne and G. Chader. Pergamon, Oxford, UK, 1990, pp. 399-426.
37. Mastronardi, L., F. Puzzilli & A. Ruggeri: Tamoxifen as a potential treatment of glioma. Anticancer Drugs 1998, 9, 581-586.
38. Miyamoto, Y. & M. A. Del Monte: Na(+)-dependent glutamate transporter in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1994, 35, 3589-3598.
39. Mäenpää, H., T. Toimela, P. Saransaari, L. Salminen & H. Tähti: Mechanism of tamoxifen's retinal toxicity studied in pig pigment epithelial cell cultures. ATLA 1997, 25, 297-302.
40. Nayfield, S. G. & M. B. Gorin: Tamoxifen-associated eye disease. A review. J. Clin. Oncol. 1996, 14, 1018-1026.
41. Newman, E. & A. Reichenbach: The Muller cell: a functional element of the retina. Trends Neurosci. 1996, 19, 307-312.
42. O'Brian, C. A., R. M. Liskamp, D. H. Solomon & I. B. Weinstein: Inhibition of protein kinase C by tamoxifen. Cancer Res. 1985, 45, 2462-2465.
43. Olney, J. W.: The toxic effects of glutamate and related compounds in the retina and the brain. Retina 1982, 2, 341-359.
44. Pan, M., M. Wasa & W. W. Souba: Protein kinase C activation inhibits glutamate transport by endothelial cells. J. Surg. Res. 1995, 58, 630-635.
45. Pautler, E. L. & C. Tengerdy: Transport of acidic amino acids by the bovine pigment epithelium. Exp. Eye Res. 1986, 43, 207-214.
46. Pavlidis, N. A., C. Petris, E. Briassoulis, G. Klouvas, C. Psilas, J. Rempapis & G. Petroutsos: Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer. 1992, 69, 2961-2964.
47. Phillis, J. W., D. Song & M. H. O'Regan: Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex. Brain Res. 1998, 780, 352-355.
48. Rauen, T., W.,R. Taylor, K. Kuhlbrodt & M. Wiessner: High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance. Cell Tissue Res. 1998, 291, 19-31.
49. Rothstein, J. D., L. Martin, A. I. Levey, M. Dykes-Hoberg, L. Jin, D. Wu, N. Nash & R. W. Kuncl: Localization of neuronal and glial glutamate transporters. Neuron 1994, 13, 713-725.
50. Salceda, R. & M. R. Saldana: Glutamate and taurine uptake by retinal pigment epithelium during rat development. Comp. Biochem. Physiol. C. 1993, 104, 311-316.
51. Singer, C. A., K. L. Rogers, T. M. Strickland & D. M. Dorsa: Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 1996, 212, 13-16.
52. Smitherman, K. A. & H. Sontheimer: Inhibition of glial Na+ and K+ currents by tamoxifen. J. Membr. Biol. 2001, 181, 125-135.
53. Stroeva, O. G. & V. I. Mitashov: Retinal pigment epithelium: proliferation and differentiation during development and regeneration. Int. Rev. Cytol. 1983, 83, 221-293.
54. Toimela, T. A. & H. Tähti: Effects of mercuric chloride exposure on the glutamate uptake by cultured retinal pigment epithelial cells. Toxicol. In Vitro. 2001, 15, 7-12.
55. Toimela, T., L. Salminen & H. Tähti: Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells. Pharmacology & Toxicology 1998, 83, 246-251.
56. Törnquist, P., A. Alm & A. Bill: Permeability of ocular vessels and transport across the blood-retinal-barrier. Eye 1990, 4 (Pt 2), 303-309.
57. Uchida, N., Y. Kiuchi, K. Miyamoto, J. Uchida, T. Tobe, M. Tomita, S. Shioda, Y. Nakai, R. Koide & K. Oguchi: Glutamate-stimulated proliferation of rat retinal pigment epithelial cells. Eur. J. Pharmacol. 1998, 343, 265-273.
58. White, R. D. & M. J. Neal: The uptake of L-glutamate by the retina. Brain Res. 1976, 111, 79-93.
59. Wilson, W.: Retinopathy during chloroquine therapy. Brit. J. Ophthalmol. 1961, 45, 756-758.
60. Young, R. W. & D. Bok: Participation of the retinal pigment epithelium in the rod outer segment renewal process. J. Cell Biol. 1969, 42, 392-403.